<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Alcohol intake and pregnancy
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Alcohol intake and pregnancy
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Alcohol intake and pregnancy
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Grace Chang, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Charles J Lockwood, MD, MHCM
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Andrew J Saxon, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen Eckler, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 13, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H450955920">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pregnant persons who drink alcohol come from all socioeconomic strata, ages, and races [
         <a href="#rid1">
          1
         </a>
         ]. These individuals may also be using other addictive or illicit substances. Both the gravida and family benefit from factual, nonjudgmental information about the maternal and fetal risks of alcohol use and, if necessary, from counseling regarding strategies for cessation. Pregnant people are typically highly motivated to modify their behavior to help their unborn child. In one national survey from the United States, 87 percent of women who self-reported consumption of alcohol before pregnancy quit drinking during pregnancy, 6.6 percent reduced their alcohol intake, and approximately 6.4 percent reported no reduction [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         This review will discuss issues regarding alcohol use in pregnancy, screening, and management. Related content on fetal alcohol spectrum disorder and use of other substances during pregnancy is presented separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14381.html" rel="external">
          "Fetal alcohol spectrum disorder: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94601.html" rel="external">
          "Fetal alcohol spectrum disorder: Management and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4799.html" rel="external">
          "Substance use during pregnancy: Screening and prenatal care"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. We encourage the reader to consider the specific counseling and treatment needs of transgender and gender-expansive individuals.
        </p>
        <p class="headingAnchor" id="H450955954">
         <span class="h1">
          EPIDEMIOLOGY OF ALCOHOL USE AND SCREENING
         </span>
        </p>
        <p class="headingAnchor" id="H3840943588">
         <span class="h2">
          Alcohol consumption
         </span>
         <span class="headingEndMark">
          —
         </span>
         Alcohol consumption during pregnancy is common [
         <a href="#rid3">
          3
         </a>
         ]. The prevalence of alcohol consumption prior to and during pregnancy highlights the need to educate all reproductive age persons about the potential harms of alcohol exposure on the developing fetus.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rising prevalence in US population
         </strong>
         – Despite public education efforts, the percent of pregnant persons consuming alcohol in the United States steadily increased across four study periods (2006 to 2010, 2011 to 2013, 2015 to 2017, and 2018 to 2020) [
         <a href="#rid3">
          3-6
         </a>
         ]. In the 2018 to 2020 survey by the Centers for Disease Control and Prevention (CDC), 5.2 percent of pregnant adults reported binge drinking within the prior 30 days and 13.5 percent reported current alcohol consumption, both of which are increased from prior surveys [
         <a href="#rid3">
          3
         </a>
         ]. Although it is possible that the rising prevalence rates represented methodologic or other changes, this seems unlikely as the data were collected by the same organization (CDC) and used similar datasets (Behavioral Risk Factor Surveillance System).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increased prevalence with extension of study period
         </strong>
         – When the time period being studied is extended, pregnant persons report higher rates of alcohol use. The 2009 National Birth Defects Prevention Study of over 4000 patients that asked about drinking behavior for the entire duration of pregnancy found that 30 percent of pregnant persons reported any alcohol use and 8 percent reported binge drinking on at least one occasion [
         <a href="#rid7">
          7
         </a>
         ]. Additionally, the 2004 Pregnancy Risk Assessment Monitoring System (PRAMS) survey that assessed preconception behavior determined that 50 percent of women self-reported alcohol use in the three months prior to pregnancy, which placed them at risk for an alcohol-exposed conception [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2558260989">
         <span class="h2">
          Screening during pregnancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although universal screening for alcohol use is advised [
         <a href="#rid9">
          9,10
         </a>
         ], evidence suggests that screening remains suboptimal [
         <a href="#rid11">
          11
         </a>
         ]. Analysis of 2017 and 2019 US Behavioral Risk Factor Surveillance Systems (BRFSS) data revealed that while approximately 80 percent of pregnant patients reported being asked about alcohol consumption at their most recent care visit, only 16 percent who reported alcohol consumption were advised to stop or reduce their alcohol use [
         <a href="#rid11">
          11
         </a>
         ]. In addition, screening for alcohol use occurred less frequently in pregnant patients who had not graduated from high school compared with those who had (53.5 versus 83.4 percent screened for alcohol use in past two years). This data supports the need for continued clinician education about universal substance screening and follow-up.
        </p>
        <p class="headingAnchor" id="H450956044">
         <span class="h1">
          SAFE LEVEL OF ALCOHOL INTAKE
         </span>
         <span class="headingEndMark">
          —
         </span>
         A safe level of alcohol consumption during pregnancy has not been determined. Thus, multiple medical societies advise against alcohol use during pregnancy [
         <a href="#rid12">
          12-14
         </a>
         ]. Assessing the impact of alcohol on fetal development is challenging because of variations in maternal alcohol clearance rates, fetal developmental sensitivity, genetic susceptibility, drinking pattern (eg, binge versus daily consumption), and confounders such as use of other substances. As alcohol is a teratogen that impacts fetal growth and development at all stages of pregnancy, national guidelines and medical societies from multiple countries recommend complete abstinence during pregnancy [
         <a href="#rid9">
          9,15-19
         </a>
         ]. Abstaining from alcohol while pregnant eliminates the risk of alcohol-related congenital anomalies and developmental disabilities, including resultant neurocognitive and behavioral problems [
         <a href="#rid15">
          15
         </a>
         ]. Use of a free online
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.acog.org%2Fwomens-health%2Finfographics%2Falcohol-and-pregnancy%3Futm_source%3Dhigher-logic%26utm_medium%3Demail%26utm_content%3Dmar-08%26utm_campaign%3Dacog2023-digest&amp;token=KMw4jckzyRfcDXxidnbjF%2FeEAOD5Zt6xfFnFY4FEcMwiDrN6IavQi90sDgpoViixj%2BAE1onGKicrTwq7QfrmZKWJ3JkJZ1fKg8oR2UaFULTziv81Mqm9HFgW%2FTT25MR84PCgZf82dz8iItfg89U6pGstu%2F3KhMLqjdltx76MigavALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=4798" target="_blank">
          infographic
         </a>
         may help convey these concerns to patients.
        </p>
        <p>
         There is no exact dose-response relationship between the amount of alcohol consumed during the prenatal period and the extent of damage caused by alcohol in the infant. Infants whose mothers consume alcohol during pregnancy can manifest fetal alcohol effects (FAE), alcohol-related birth defects (ARBD), fetal alcohol syndrome (FAS), or they may be normal [
         <a href="#rid20">
          20
         </a>
         ]. The term fetal alcohol spectrum disorder (FASD) has been coined to describe the broad range of adverse sequelae in alcohol exposed offspring [
         <a href="#rid21">
          21
         </a>
         ]. A 2018 study of over 6600 United States first grade students from four different communities reported conservative estimates of FASD that ranged from 1.1 to 5.0 percent [
         <a href="#rid22">
          22
         </a>
         ]. FAS represents the most severe sequelae of fetal alcohol exposure; however, there is a continuum of outcomes associated with prenatal exposure to alcohol that varies by parameter being studied.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Structural development
         </strong>
         – A prospective cohort study obtained detailed information about self-reported alcohol consumed three months before pregnancy and for each trimester, including the time prior to pregnancy recognition, from 415 White patients in Australia [
         <a href="#rid23">
          23
         </a>
         ]. The researchers then assessed three-dimensional craniofacial images of 415 children taken at 12 months of age. Results from this study, which relied on maternal self-report of alcohol use [
         <a href="#rid24">
          24
         </a>
         ], suggest that low levels of prenatal alcohol use can influence craniofacial development of the fetus. However, the clinical significance of these findings remains to be determined.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Birth outcomes
         </strong>
         – Although a systematic review did not find a significant increase in risk of low birth weight or birth of a small for gestational age infant for alcohol intake up to 10 g pure alcohol/day (approximately one drink per day) or an increase in preterm birth for alcohol intake up to 18 g pure alcohol/day (approximately 1.5 drinks per day), the risk of these outcomes progressively increased and became statistically significant with greater alcohol consumption [
         <a href="#rid25">
          25
         </a>
         ]. This review did not evaluate the risk of alcohol-related fetal damage (FAE, ARBD, FAS, FASD), which is an important limitation to the conclusions of the meta-analysis. Furthermore, the studies included in the meta-analysis relied on self-reports of alcohol consumption and did not take patterns of alcohol use into account. As such, it did not provide definitive information about the risks associated with light to moderate prenatal alcohol.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neurodevelopmental outcomes
         </strong>
         – Available data conflict regarding the neurodevelopmental impact of alcohol consumption during pregnancy. This likely reflects the complex interaction of gestational age, dose and duration of alcohol exposure, underlying variations in maternal alcohol metabolism, and duration of study follow-up. Examples of studies evaluating this question, and their limitations, include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A series of studies from Denmark that evaluated the effects of maternal self-report of low to moderate alcohol consumption (&lt;9 drinks/week) in early to mid-pregnancy on developmental outcomes (IQ, attention, executive function, motor function, behavior) in 5-year-old children did not find significant effects [
         <a href="#rid26">
          26-31
         </a>
         ]. However, there are several limitations to these data. The Danish studies did not conduct FAS diagnostic evaluations and they assessed only preschoolers, which can be misleading because these children were too young to for the full impact alcohol may have had on their brains to be measured.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         On the other hand, a large well-designed study from Washington state that followed children up to age 18 demonstrated the importance of longitudinal follow-up in ascertaining the effects of prenatal alcohol exposure [
         <a href="#rid32">
          32
         </a>
         ]. Specific findings included that although half of older children with FAS exhibited normal developmental scores as preschoolers, all had severe brain dysfunction confirmed by age 10; only 10 percent of children with FAS had attention problems by age 5 but 60 percent had attention problems by the age of 10; and only 30 percent of children with FAS had an IQ below normal, but 100 percent had severe dysfunction in other areas such as language, memory and activity level, which the Danish study did not assess [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Patterns of maternal alcohol consumption and socioeconomic and ethnic factors also affect outcome. As an example, binge drinking may exert a potentially greater negative effect than comparable consumption of low amounts of alcohol over several days (eg, four drinks in one sitting versus one drink a day for four days) [
         <a href="#rid34">
          34-36
         </a>
         ], but this is also controversial [
         <a href="#rid26">
          26-30
         </a>
         ]. Affluent pregnant persons tend to be better educated and have access to resources that may be less available to less affluent pregnant persons; these resources may confound conclusions by overcoming some of alcohol's negative impact on childhood development [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
         For unknown reasons, older maternal age, high parity, and African-American or Native American ethnicities appear to increase the risk of FAS. Other characteristics associated with those at higher risk for having an alcohol exposed pregnancy include low socioeconomic status, smoking, unmarried, unemployed, use of illicit drugs, history of sexual or physical abuse or neglect, history of incarceration, having a partner or family member who drinks heavily, being socially transient, and having psychologic stress or a mental health disorder [
         <a href="#rid38">
          38,39
         </a>
         ].
        </p>
        <p>
         Alcohol freely crosses the placenta: fetal blood alcohol levels approach maternal levels within two hours of maternal intake. Elimination of alcohol relies primarily on maternal metabolic capacity, which varies widely among pregnant individuals and may help explain why similar amounts of ethanol consumption result in widely varying phenotypic presentations in infants [
         <a href="#rid40">
          40
         </a>
         ]. Polymorphisms of the alcohol dehydrogenase gene could explain variations in blood alcohol levels among individuals ingesting the same amount of ethanol. Maternal, and possibly fetal, polymorphisms of the gene ADH1B appear to contribute to FASD susceptibility [
         <a href="#rid41">
          41
         </a>
         ]. It is hypothesized that the gene affects peak blood alcohol levels that, in turn, correlate with the risk of adverse fetal effects [
         <a href="#rid41">
          41-43
         </a>
         ]. ADH1B polymorphisms may affect alcohol levels by affecting alcohol metabolism [
         <a href="#rid44">
          44
         </a>
         ]. Expression of the cytochrome P450 E1 (CYP2E1) gene also affects alcohol metabolism and may play a role in vulnerability to FAS.
        </p>
        <p class="headingAnchor" id="H450956500">
         <span class="h1">
          PERINATAL OUTCOMES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Alcohol is a teratogen with the potential to cause deleterious effects at all stages of gestation. The effects vary depending upon the quantity and pattern of alcohol consumption, maternal and fetal genetics, maternal age, maternal nutrition, and smoking, among other factors. The most severe consequences of prenatal alcohol exposure are stillbirth and fetal alcohol spectrum disorder (FASD), which encompasses the physical, mental, behavioral, and cognitive effects associated with in utero alcohol exposure. In two large epidemiologic studies, an increased rate of stillbirth was noted across all categories of alcohol intake, even after adjusting for confounders (eg, smoking, prepregnancy weight) [
         <a href="#rid45">
          45,46
         </a>
         ]. The rate of death from fetoplacental dysfunction rose from 1.37 per 1000 births for patients consuming less than one drink per week to 8.83 per 1000 births for those consuming greater than or equal to five drinks per week. The clinical features, diagnosis, management, and prognosis of FASD are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/14381.html" rel="external">
          "Fetal alcohol spectrum disorder: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94601.html" rel="external">
          "Fetal alcohol spectrum disorder: Management and prognosis"
         </a>
         .)
        </p>
        <p>
         There is continuing uncertainty about the effects of low and low-to-moderate levels of alcohol intake in pregnancy. Although several studies have not found adverse behavioral and developmental effects, these studies have several methodologic limitations [
         <a href="#rid20">
          20,47-50
         </a>
         ]. As discussed above, a prospective cohort study of data collected from 2011 to 2014 reported craniofacial changes with almost any level of prenatal alcohol intake, but clinical significance of these changes is not known [
         <a href="#rid23">
          23
         </a>
         ]. A different prospective cohort study (data from 2000 to 2020) of over 5300 urban United States patients reported that alcohol use during weeks 5 through 10 (from last menstrual period) was associated with increased risk of early pregnancy loss, with peak risk in week 9 [
         <a href="#rid51">
          51
         </a>
         ]. Each successive week of alcohol consumption resulted in an 8 percent increase in risk of pregnancy loss compared with nonusers, and the risk was cumulative. In this study, risk of pregnancy loss was not related to number of drinks per week, type of alcohol consumed, or binge drinking. A different retrospective study of 9700 youths ages 9.0 to 10.9 years reported any degree of prenatal alcohol exposure was associated with greater psychopathology, attention deficits, and impulsiveness [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
         Higher quality studies related to this type of drinking are needed. Hence, there is no confirmed "safe" threshold of alcohol exposure during pregnancy so avoiding alcohol may be the most prudent approach. (See
         <a class="local">
          'Safe level of alcohol intake'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H450956643">
         <span class="h1">
          SCREENING FOR ALCOHOL MISUSE
         </span>
        </p>
        <p class="headingAnchor" id="H450956649">
         <span class="h2">
          History
         </span>
         <span class="headingEndMark">
          —
         </span>
         All pregnant persons should be screened for use of licit and illicit substances [
         <a href="#rid9">
          9,53
         </a>
         ]. Many screening options are possible, from self-administered questionnaires to analysis of biological samples taken from the pregnant woman or her offspring. A practical, effective approach is to interview each woman with respectful and sensitive use of neutrally worded questions. It is preferable to begin by asking about lawful substances, such as cigarette smoking and alcohol, followed by questions about illicit drugs.
        </p>
        <p>
         The typical questions asked about the quantity and frequency of alcohol use are less helpful in the assessment of prenatal alcohol consumption than in other populations. This discordancy is due to modification of alcohol consumption once pregnancy is recognized and the fact that traditional alcohol screening measures were developed in males with alcohol use disorders [
         <a href="#rid54">
          54
         </a>
         ]. In addition, admission of alcohol use during pregnancy can be stigmatizing; thus, pregnant individuals may be reluctant to admit to any amount of drinking.
        </p>
        <p>
         Clinicians can choose screening strategies that are appropriate for their clinical population and setting. T-ACE, TWEAK, and AUDIT-C are brief alcohol screening questionnaires used to identify problem drinking in pregnant persons. In a systematic review of these instruments and others (CAGE, SMAST), at-risk drinking sensitivity was highest for T-ACE (69 to 88 percent), TWEAK (71 to 91 percent), and AUDIT-C (95 percent), with high specificity (71 to 89 percent, 73 to 83 percent, and 85 percent, respectively) [
         <a href="#rid55">
          55
         </a>
         ]. CAGE and SMAST performed poorly. Sensitivity of AUDIT-C at score ≥3 was 100 percent for past year DSM-IV alcohol dependence and 90 percent for alcohol use disorder, with moderate specificity (71 percent for each).
        </p>
        <p class="headingAnchor" id="H450956709">
         <span class="h3">
          T-ACE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The T-ACE is a simple screening instrument for alcohol use designed specifically for the prenatal setting [
         <a href="#rid56">
          56
         </a>
         ]. It identifies a range of alcohol consumption from any current prenatal drinking, prepregnancy risk drinking defined as more than two drinks per drinking day, to lifetime alcohol diagnoses based on the Diagnostic and Statistical Manual of Mental Disorders [
         <a href="#rid57">
          57
         </a>
         ]. The T-ACE questions are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         How many drinks does it take for you to feel high (
         <strong>
          TOLERANCE
         </strong>
         )?
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Do you feel
         <strong>
          ANNOYED
         </strong>
         by people complaining about your drinking?
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Have you ever felt the need to
         <strong>
          CUT
         </strong>
         down on your drinking?
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Have you ever had a drink first thing in the morning (
         <strong>
          EYE-OPENER
         </strong>
         )?
        </p>
        <p>
        </p>
        <p>
         One point is given for each affirmative answer to the
         <strong>
          A
         </strong>
         nnoy,
         <strong>
          C
         </strong>
         ut-down, and
         <strong>
          E
         </strong>
         ye-opener questions; 2 points are allotted if a woman reports tolerance to more than two drinks. A score of 2 or more is a positive score. The overall sensitivity (ie, the probability that a woman who is a risk drinker scores positive) of T-ACE is 69 percent, with specificity of 85 percent [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H450956757">
         <span class="h3">
          TWEAK
         </span>
         <span class="headingEndMark">
          —
         </span>
         TWEAK is another screening instrument used in pregnant persons:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         T =
         <strong>
          TOLERANCE
         </strong>
         for alcohol
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         W =
         <strong>
          WORRY
         </strong>
         or concern by family or friends about drinking behavior
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         E =
         <strong>
          EYE OPENER
         </strong>
         , the need to have a drink in the morning
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A = "blackouts" or
         <strong>
          AMNESIA
         </strong>
         while drinking
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         K = the self-perception of the need to
         <strong>
          CUT DOWN
         </strong>
         on alcohol use
        </p>
        <p>
        </p>
        <p>
         Scores range from 0 to 7. The tolerance and worry questions each contribute 2 points and the other three questions contribute 1 point each. Any endorsement of the worry question is scored a 2; on the tolerance question, if three or more drinks are needed to feel high, the question is scored as a 2. Other versions of the
         <strong>
          TOLERANCE
         </strong>
         question ask:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         How many drinks does it take before the alcohol makes you fall asleep or pass out?
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If you never drink till you pass out, what is the largest number of drinks you have or can hold?
        </p>
        <p>
        </p>
        <p>
         If the woman answers "five or more drinks," these questions are given a score of 2 points.
        </p>
        <p>
         A total score of ≥3 on the TWEAK is suggestive of heavy drinking patterns [
         <a href="#rid58">
          58-60
         </a>
         ]. However, both the TWEAK and TACE tests can miss light drinking, and sensitivity varies by ethnic group [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H450956819">
         <span class="h3">
          AUDIT-C
         </span>
         <span class="headingEndMark">
          —
         </span>
         A third option for a brief screening questionnaire is the AUDIT-C. In this system, a total score of ≥3 points is positive for women.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         How often have you had a drink containing alcohol in the past year?
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Never: 0 points
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Monthly or less: 1 point
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Two to four times a month: 2 points
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Three times a week: 3 points
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Four times or more per week: 4 points
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         How many drinks did you have on a typical day when you were drinking in the past year?
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         One or two: 0 points
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Three or four: 1 point
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Five or six: 2 points
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Seven to nine: 3 points
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         10 or more: 4 points
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         How often did you have six or more drinks on one occasion during the past year?
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Never: 0 points
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Monthly or less: 1 point
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Monthly: 2 points
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Weekly: 3 points
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Daily or almost daily: 4 points
        </p>
        <p>
        </p>
        <p>
         An in-depth discussion of screening and diagnosis of individuals with alcohol problems can be found separately. (See
         <a class="medical medical_review" href="/z/d/html/14843.html" rel="external">
          "Screening for unhealthy use of alcohol and other drugs in primary care", section on 'Special populations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H450956837">
         <span class="h2">
          Laboratory testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         The reference standard in detecting alcohol fetal exposure is maternal self-report [
         <a href="#rid61">
          61
         </a>
         ]. Recent alcohol intake is evaluated by measuring the blood alcohol level; this level can be estimated by breathalyzer. However, individual variability in ethanol pharmacokinetics makes interpretation of alcohol levels challenging. Chronic alcohol consumption may be suspected based upon abnormalities of liver function tests, macrocytosis, anemia, or carbohydrate-deficient transferrin (which is affected by pregnancy).
        </p>
        <p>
         Hence, the use of biomarkers for prenatal alcohol exposure has been proposed as an adjunct for both research and clinical purposes [
         <a href="#rid61">
          61
         </a>
         ]. Although there is no agreement among research groups concerning the best method for analyzing biological samples or when these tests should be used in pregnant individuals, several biomarkers have been suggested. These include phosphatidyl ethanol (PEth), fatty acid ethyl esters (FAEEs), and ethyl glucuronide (EtG).
        </p>
        <p>
         PEth has a long half-life and is measurable for up to six weeks after intake; a blood sample is required [
         <a href="#rid62">
          62
         </a>
         ]. FAEEs are a direct biomarker of alcohol that persists in blood for at least 24 hours after the last alcohol intake and can also be detected in maternal hair and neonatal meconium [
         <a href="#rid61">
          61,63
         </a>
         ]. EtG is a very sensitive and specific biomarker of alcohol exposure because it is detectable only if alcohol has been consumed. EtG can be found in serum or urine but has a low incorporation rate in hair. EtG is detectable in urine specimens one hour after alcohol intake and up to five days later [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p>
         There are many limitations to widespread utilization of biomarkers. These include the need to identify the optimal combination of self-report and the biomarkers themselves. Patient acceptability and cost of these analyses may limit widespread implementation. (See
         <a class="medical medical_review" href="/z/d/html/14843.html" rel="external">
          "Screening for unhealthy use of alcohol and other drugs in primary care", section on 'Special populations'
         </a>
         .)
        </p>
        <p>
         Positive tests can have legal and economic implications. Patients should give informed consent prior to laboratory testing; random testing is unethical [
         <a href="#rid65">
          65-67
         </a>
         ]. Medically indicated alcohol testing without written consent is acceptable in individuals who are unconscious or show obvious signs of intoxication and need to be tested to provide the appropriate medical interventions. Clinicians should be aware of their state's requirements for testing and reporting drug test results.
        </p>
        <p class="headingAnchor" id="H450956911">
         <span class="h1">
          MANAGEMENT OF SCREEN-POSITIVE PREGNANT PERSONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Consistent screening for alcohol use followed by education, assessment, and treatment referral, if indicated, are effective and will help to ensure the best possible outcome for all pregnant persons and their babies [
         <a href="#rid68">
          68,69
         </a>
         ]. Linking substance use disorder treatment with prenatal care has a positive effect on maternal and newborn health [
         <a href="#rid70">
          70
         </a>
         ]. Maternal cessation of alcohol intake at any point during pregnancy is beneficial as children born to individuals who stop drinking even late in gestation have better outcomes than those born to individuals who continue to drink throughout pregnancy [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
         A positive screen provides an opportunity to proceed with a careful, nonjudgmental assessment of the patient's current and past alcohol consumption. This focus on drinking behavior can be beneficial, as the assessment of alcohol intake itself and the counseling and support provided by a nonjudgmental clinician can motivate some patients to abstain. This was illustrated in a trial that randomized 250 pregnant patients with a positive alcohol screen to either comprehensive alcohol assessment only or to the same comprehensive assessment with a brief intervention [
         <a href="#rid72">
          72
         </a>
         ]. Both groups reduced their antepartum alcohol consumption by one to two thirds and brief intervention helped abstinent individuals remain abstinent. By comparison, US state-level pregnancy-specific policies focused on reducing alcohol use during pregnancy, such as reporting requirements for suspicion or evidence of alcohol use, have not been associated with reduced harm to infants [
         <a href="#rid73">
          73
         </a>
         ].
        </p>
        <p>
         Randomized and controlled trials show that brief intervention for alcohol problems is more effective than no intervention, and often as effective as more extensive intervention [
         <a href="#rid74">
          74-79
         </a>
         ]. Reported benefits of intervention include reduced alcohol consumption [
         <a href="#rid78">
          78,79
         </a>
         ], reduced risk for an alcohol-exposed pregnancy [
         <a href="#rid74">
          74
         </a>
         ], higher rates of abstinence [
         <a href="#rid75">
          75
         </a>
         ], and improvement in fetal and newborn outcomes [
         <a href="#rid75">
          75
         </a>
         ]. In one randomized trial, including a partner chosen by the patient during treatment led to greater reduction in alcohol use, particularly among heavy drinkers [
         <a href="#rid78">
          78
         </a>
         ].
        </p>
        <p>
         Some individuals with alcohol use disorder require referral for in-depth counseling and treatment regimens. Patients identified to have heavy drinking patterns and who are unlikely to reduce their consumption should be referred to professional alcohol treatment. (See
         <a class="medical medical_review" href="/z/d/html/108891.html" rel="external">
          "Alcohol use disorder: Treatment overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7810.html" rel="external">
          "Alcohol use disorder: Psychosocial management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H450957203">
         <span class="h1">
          PREGNANCY MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Comprehensive prenatal care can ameliorate some of the maternal and neonatal complications of maternal substance use. The components of this care include [
         <a href="#rid65">
          65
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Screening of all pregnant persons for alcohol use.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Counseling regarding the risks of alcohol use.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Assembling a multidisciplinary team of health care and social service providers to comprehensively assess gravidas who use alcohol and their offspring.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Scheduling frequent prenatal visits to monitor maternal and fetal status and provide education and support.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obtaining an early ultrasound examination to confirm gestational age and establish an accurate baseline for following fetal growth.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beginning antepartum fetal surveillance if there is evidence of pregnancy complications (eg, growth restriction, third trimester bleeding, maternal withdrawal).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Informing the pediatrician of the possibility of neonatal withdrawal.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Discouraging breastfeeding in individuals who continue to consume alcohol.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3178448185">
         <span class="h1">
          RESOURCES FOR PATIENTS AND CLINICIANS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The American College of Obstetricians and Gynecologists (ACOG) offers an online Frequently Asked Questions infographic on "
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.acog.org%2Fwomens-health%2Finfographics%2Falcohol-and-pregnancy%3Futm_source%3Dhigher-logic%26utm_medium%3Demail%26utm_content%3Dmar-08%26utm_campaign%3Dacog2023-digest&amp;token=KMw4jckzyRfcDXxidnbjF%2FeEAOD5Zt6xfFnFY4FEcMwiDrN6IavQi90sDgpoViixj%2BAE1onGKicrTwq7QfrmZKWJ3JkJZ1fKg8oR2UaFULTziv81Mqm9HFgW%2FTT25MR84PCgZf82dz8iItfg89U6pGstu%2F3KhMLqjdltx76MigavALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=4798" target="_blank">
          Alcohol and Pregnancy
         </a>
         " that is available for free in both English and Spanish.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The US Centers for Disease Control and Prevention (CDC) offers free communication materials for health care providers and patients on
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fncbddd%2Ffasd%2Fpartners-tools.html&amp;token=wNA4NCbPaznbdAW3wGgYxrZbtPHMVuvY51rXqPqoy3y8c6TKbNiVOsY4mr1eJ7w232loamkSHo%2FxIoJORHvNHA%3D%3D&amp;TOPIC_ID=4798" target="_blank">
          alcohol and pregnancy
         </a>
         , including their "
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fncbddd%2Ffasd%2Fdocuments%2FLetsTalkCommunicationGuide-508.pdf&amp;token=ws2SceRXhPRxn5OXs%2FBIwYpaiBFVvlUT9YI%2BLLVTRjEJl94UHdjTL5RlBKb6dXi6GdxE9OWYHua5V%2FomcR27FaJoE1QmNAwxeWMtO%2FJar%2BIHzrsHsMIrWvTR69mjeLZ%2F&amp;TOPIC_ID=4798" target="_blank">
          Let’s Talk
         </a>
         " communication aid.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1967396931">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/123018.html" rel="external">
          "Society guideline links: Alcohol consumption"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/118165.html" rel="external">
          "Society guideline links: Substance misuse in pregnancy"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/118147.html" rel="external">
          "Society guideline links: Fetal alcohol spectrum disorder"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H450957223">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/85731.html" rel="external">
          "Patient education: Alcohol and drug use in pregnancy (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/83399.html" rel="external">
          "Patient education: Fetal alcohol syndrome (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H450957260">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Alcohol use in pregnancy is common
         </strong>
         – More than one-half of all females of childbearing age (18 to 44 years of age) report alcohol use, and one in eight report binge drinking in the past month. (See
         <a class="local">
          'Epidemiology of alcohol use and screening'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Negative effects of prenatal alcohol consumption
         </strong>
         – Alcohol consumption appears to have negative effects throughout pregnancy, including teratogenic effects and increased risk of pregnancy loss. (See
         <a class="local">
          'Perinatal outcomes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lack of dose-response relationship
         </strong>
         – There is no exact dose-response relationship between the amount of alcohol consumed during the prenatal period and the extent of damage caused by alcohol in the infant. We recommend abstinence from alcohol at conception and during pregnancy (
         <a class="grade" href="https:///uptodate/show/grade_3" rel="external">
          Grade 1C
         </a>
         ). (See
         <a class="local">
          'Safe level of alcohol intake'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Screening for alcohol use during pregnancy
         </strong>
         – Identification and counseling of pregnant persons who use alcohol can decrease intake during pregnancy. Given that alcohol is a known teratogen and a safe level of intake during pregnancy has not been established, we recommend screening all pregnant individuals for any use of alcohol (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). (See
         <a class="local">
          'Screening for alcohol misuse'
         </a>
         above and
         <a class="local">
          'Management of screen-positive pregnant persons'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Screening tools
         </strong>
         – The T-ACE, TWEAK, or AUDIT-C screening tool can be used to identify individuals who may be at risk for prenatal alcohol use. Clinicians should choose a screening strategy that is appropriate for their clinical population and setting. (See
         <a class="local">
          'Screening for alcohol misuse'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intervention options
         </strong>
         – For pregnant persons who consume alcohol but are not heavy drinkers, we recommend a brief intervention (eg, educational session(s), motivational counseling) rather than no intervention or more extensive alcohol cessation programs (
         <a class="grade" href="https:///uptodate/show/grade_1" rel="external">
          Grade 1A
         </a>
         ). Individuals with heavy drinking patterns who are unlikely to reduce their consumption should be referred to professional alcohol treatment. (See
         <a class="local">
          'Management of screen-positive pregnant persons'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Chasnoff IJ, McGourty RF, Bailey GW, et al. The 4P's Plus screen for substance use in pregnancy: clinical application and outcomes. J Perinatol 2005; 25:368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kitsantas P, Gaffney KF, Wu H, Kastello JC. Determinants of alcohol cessation, reduction and no reduction during pregnancy. Arch Gynecol Obstet 2014; 289:771.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gosdin LK, Deputy NP, Kim SY, et al. Alcohol Consumption and Binge Drinking During Pregnancy Among Adults Aged 18-49 Years - United States, 2018-2020. MMWR Morb Mortal Wkly Rep 2022; 71:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan CH, Denny CH, Cheal NE, et al. Alcohol use and binge drinking among women of childbearing age - United States, 2011-2013. MMWR Morb Mortal Wkly Rep 2015; 64:1042.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Alcohol use and binge drinking among women of childbearing age--United States, 2006-2010. MMWR Morb Mortal Wkly Rep 2012; 61:534.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Denny CH, Acero CS, Naimi TS, Kim SY. Consumption of Alcohol Beverages and Binge Drinking Among Pregnant Women Aged 18-44 Years - United States, 2015-2017. MMWR Morb Mortal Wkly Rep 2019; 68:365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ethen MK, Ramadhani TA, Scheuerle AE, et al. Alcohol consumption by women before and during pregnancy. Matern Child Health J 2009; 13:274.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Angelo D, Williams L, Morrow B, et al. Preconception and interconception health status of women who recently gave birth to a live-born infant--Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveill Summ 2007; 56:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American College of Obstetricians and Gynecologists. Committee on Health Care for Underserved Women. Committee opinion no. 496: At-risk drinking and alcohol dependence: obstetric and gynecologic implications. Obstet Gynecol 2011; 118:383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA 2018; 320:1899.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luong J, Board A, Gosdin L, et al. Alcohol Use, Screening, and Brief Intervention Among Pregnant Persons - 24 U.S. Jurisdictions, 2017 and 2019. MMWR Morb Mortal Wkly Rep 2023; 72:55.
          </a>
         </li>
         <li class="breakAll">
          Department of Health. UK Chief Medical Officers’ alcohol guidelines review: summary of the proposed new guidelines. 2016. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/489795/summary.pdf (Accessed on May 20, 2020).
         </li>
         <li class="breakAll">
          Australian Government Department of Health. Australian guidelines to reduce health risks from drinking alcohol. 2009. https://www.nhmrc.gov.au/about-us/publications/australian-guidelines-reduce-health-risks-drinking-alcohol (Accessed on May 20, 2020).
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Alcohol and pregnancy. 2016. https://www.cdc.gov/dotw/fasd/ (Accessed on May 20, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams JF, Smith VC, COMMITTEE ON SUBSTANCE ABUSE. Fetal Alcohol Spectrum Disorders. Pediatrics 2015; 136:e1395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carson G, Cox LV, Crane J, et al. Alcohol use and pregnancy consensus clinical guidelines. J Obstet Gynaecol Can 2010; 32:S1.
          </a>
         </li>
         <li class="breakAll">
          Australian Guidelines: To reduce health risks from drinking alcohol https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/ds10-alcohol.pdf (Accessed on October 21, 2015).
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention: Fetal alcohol spectrum disorders (FASDs) http://www.cdc.gov/ncbddd/fasd/alcohol-use.html (Accessed on October 21, 2015).
         </li>
         <li class="breakAll">
          New Zealand Government: Alcohol and Pregnancy https://www.health.govt.nz/system/files/documents/publications/alcohol-pregnancy-practical-guide-health-professionals.pdf (Accessed on October 21, 2015).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henderson J, Gray R, Brocklehurst P. Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome. BJOG 2007; 114:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koren G, Nulman I, Chudley AE, Loocke C. Fetal alcohol spectrum disorder. CMAJ 2003; 169:1181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           May PA, Chambers CD, Kalberg WO, et al. Prevalence of Fetal Alcohol Spectrum Disorders in 4 US Communities. JAMA 2018; 319:474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muggli E, Matthews H, Penington A, et al. Association Between Prenatal Alcohol Exposure and Craniofacial Shape of Children at 12 Months of Age. JAMA Pediatr 2017; 171:771.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muggli E, O'Leary C, Forster D, et al. Study protocol: Asking QUestions about Alcohol in pregnancy (AQUA): a longitudinal cohort study of fetal effects of low to moderate alcohol exposure. BMC Pregnancy Childbirth 2014; 14:302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patra J, Bakker R, Irving H, et al. Dose-response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)-a systematic review and meta-analyses. BJOG 2011; 118:1411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Falgreen Eriksen HL, Mortensen EL, Kilburn T, et al. The effects of low to moderate prenatal alcohol exposure in early pregnancy on IQ in 5-year-old children. BJOG 2012; 119:1191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Underbjerg M, Kesmodel US, Landrø NI, et al. The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on selective and sustained attention in 5-year-old children. BJOG 2012; 119:1211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skogerbø Å, Kesmodel US, Wimberley T, et al. The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on executive function in 5-year-old children. BJOG 2012; 119:1201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kesmodel US, Bertrand J, Støvring H, et al. The effect of different alcohol drinking patterns in early to mid pregnancy on the child's intelligence, attention, and executive function. BJOG 2012; 119:1180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bay B, Støvring H, Wimberley T, et al. Low to moderate alcohol intake during pregnancy and risk of psychomotor deficits. Alcohol Clin Exp Res 2012; 36:807.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skogerbø Å, Kesmodel US, Denny CH, et al. The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on behaviour in 5-year-old children: a prospective cohort study on 1628 children. BJOG 2013; 120:1042.
          </a>
         </li>
         <li class="breakAll">
          http://depts.washington.edu/fasdpn/ (Accessed on August 30, 2012).
         </li>
         <li class="breakAll">
          Astley S, Grant T. Alcohol and Pregnancy: Another perspective on the Disputed Danish Studies http://depts.washington.edu/fasdpn/pdfs/astley-grant-Washington.pdf (Accessed on August 30, 2012).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maier SE, West JR. Drinking patterns and alcohol-related birth defects. Alcohol Res Health 2001; 25:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bailey BN, Delaney-Black V, Covington CY, et al. Prenatal exposure to binge drinking and cognitive and behavioral outcomes at age 7 years. Am J Obstet Gynecol 2004; 191:1037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henderson J, Kesmodel U, Gray R. Systematic review of the fetal effects of prenatal binge-drinking. J Epidemiol Community Health 2007; 61:1069.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gray R. Low-to-moderate alcohol consumption during pregnancy and child development--moving beyond observational studies. BJOG 2013; 120:1039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Floyd RL, O'Connor MJ, Sokol RJ, et al. Recognition and prevention of fetal alcohol syndrome. Obstet Gynecol 2005; 106:1059.
          </a>
         </li>
         <li class="breakAll">
          Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis. National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and Prevention Department of Health and Human Services. July 2004. www.cdc.gov/ncbddd/fas/default.htm (Accessed on November 10, 2005).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burd L, Blair J, Dropps K. Prenatal alcohol exposure, blood alcohol concentrations and alcohol elimination rates for the mother, fetus and newborn. J Perinatol 2012; 32:652.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warren KR, Li TK. Genetic polymorphisms: impact on the risk of fetal alcohol spectrum disorders. Birth Defects Res A Clin Mol Teratol 2005; 73:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobson SW, Carr LG, Croxford J, et al. Protective effects of the alcohol dehydrogenase-ADH1B allele in children exposed to alcohol during pregnancy. J Pediatr 2006; 148:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoler JM, Ryan LM, Holmes LB. Alcohol dehydrogenase 2 genotypes, maternal alcohol use, and infant outcome. J Pediatr 2002; 141:780.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Green RF, Stoler JM. Alcohol dehydrogenase 1B genotype and fetal alcohol syndrome: a HuGE minireview. Am J Obstet Gynecol 2007; 197:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kesmodel U, Wisborg K, Olsen SF, et al. Moderate alcohol intake during pregnancy and the risk of stillbirth and death in the first year of life. Am J Epidemiol 2002; 155:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Odendaal H, Dukes KA, Elliott AJ, et al. Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth. JAMA Netw Open 2021; 4:e2121726.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bay B, Kesmodel US. Prenatal alcohol exposure - a systematic review of the effects on child motor function. Acta Obstet Gynecol Scand 2011; 90:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Leary CM, Nassar N, Kurinczuk JJ, Bower C. The effect of maternal alcohol consumption on fetal growth and preterm birth. BJOG 2009; 116:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelly Y, Sacker A, Gray R, et al. Light drinking in pregnancy, a risk for behavioural problems and cognitive deficits at 3 years of age? Int J Epidemiol 2009; 38:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Todorow M, Moore TE, Koren G. Investigating the effects of low to moderate levels of prenatal alcohol exposure on child behaviour: a critical review. J Popul Ther Clin Pharmacol 2010; 17:e323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sundermann AC, Velez Edwards DR, Slaughter JC, et al. Week-by-week alcohol consumption in early pregnancy and spontaneous abortion risk: a prospective cohort study. Am J Obstet Gynecol 2021; 224:97.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lees B, Mewton L, Jacobus J, et al. Association of Prenatal Alcohol Exposure With Psychological, Behavioral, and Neurodevelopmental Outcomes in Children From the Adolescent Brain Cognitive Development Study. Am J Psychiatry 2020; 177:1060.
          </a>
         </li>
         <li class="breakAll">
          Stratton, K, Howe, C, Battaglia, F (eds). Institute of Medicine Summary: Fetal Alcohol Syndrome Washington, DC: National Academy Press, 1996.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Babor TF, Kranzler HR, Lauerman RJ. Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self-report screening procedures. Addict Behav 1989; 14:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burns E, Gray R, Smith LA. Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review. Addiction 2010; 105:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sokol RJ, Martier SS, Ager JW. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol 1989; 160:863.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang G, Wilkins-Haug L, Berman S, et al. Alcohol use and pregnancy: improving identification. Obstet Gynecol 1998; 91:892.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan AW, Pristach EA, Welte JW, Russell M. Use of the TWEAK test in screening for alcoholism/heavy drinking in three populations. Alcohol Clin Exp Res 1993; 17:1188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Connor MJ, Whaley SE. Alcohol use in pregnant low-income women. J Stud Alcohol 2003; 64:773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradley KA, Boyd-Wickizer J, Powell SH, Burman ML. Alcohol screening questionnaires in women: a critical review. JAMA 1998; 280:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bager H, Christensen LP, Husby S, Bjerregaard L. Biomarkers for the Detection of Prenatal Alcohol Exposure: A Review. Alcohol Clin Exp Res 2017; 41:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kwak HS, Han JY, Choi JS, et al. Characterization of phosphatidylethanol blood concentrations for screening alcohol consumption in early pregnancy. Clin Toxicol (Phila) 2014; 52:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joya X, Friguls B, Ortigosa S, et al. Determination of maternal-fetal biomarkers of prenatal exposure to ethanol: a review. J Pharm Biomed Anal 2012; 69:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wurst FM, Kelso E, Weinmann W, et al. Measurement of direct ethanol metabolites suggests higher rate of alcohol use among pregnant women than found with the AUDIT--a pilot study in a population-based sample of Swedish women. Am J Obstet Gynecol 2008; 198:407.e1.
          </a>
         </li>
         <li class="breakAll">
          American College of Obstetricians and Gynecologists. Special issues in women's health. ACOG, Washington, DC 2005.
         </li>
         <li>
          <a class="nounderline abstract_t">
           American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 422: at-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. Obstet Gynecol 2008; 112:1449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zizzo N, Di Pietro N, Green C, et al. Comments and reflections on ethics in screening for biomarkers of prenatal alcohol exposure. Alcohol Clin Exp Res 2013; 37:1451.
          </a>
         </li>
         <li class="breakAll">
          Surgeon General's Advisory on Alcohol Use in Pregnancy. www.hhs.gov/surgeongeneral/pressreleases/sg02222005.html (Accessed on December 14, 2007).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rayburn WF, Bogenschutz MP. Pharmacotherapy for pregnant women with addictions. Am J Obstet Gynecol 2004; 191:1885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goler NC, Armstrong MA, Taillac CJ, Osejo VM. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. J Perinatol 2008; 28:597.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coles DC, Smith IE, Lancaster JS, Falek A. Persistence over the first month of neurobehavioral alterations in infants exposed to alcohol prenatally. Infant Behav Dev 1987; 10:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang G, Wilkins-Haug L, Berman S, Goetz MA. Brief intervention for alcohol use in pregnancy: a randomized trial. Addiction 1999; 94:1499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts SCM, Schulte A, Zaugg C, et al. Association of Pregnancy-Specific Alcohol Policies With Infant Morbidities and Maltreatment. JAMA Netw Open 2023; 6:e2327138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Floyd RL, Sobell M, Velasquez MM, et al. Preventing alcohol-exposed pregnancies: a randomized controlled trial. Am J Prev Med 2007; 32:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Connor MJ, Whaley SE. Brief intervention for alcohol use by pregnant women. Am J Public Health 2007; 97:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang G, McNamara TK, Orav EJ, Wilkins-Haug L. Brief intervention for prenatal alcohol use: the role of drinking goal selection. J Subst Abuse Treat 2006; 31:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ingersoll KS, Ceperich SD, Nettleman MD, et al. Reducing alcohol-exposed pregnancy risk in college women: initial outcomes of a clinical trial of a motivational intervention. J Subst Abuse Treat 2005; 29:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang G, McNamara TK, Orav EJ, et al. Brief intervention for prenatal alcohol use: a randomized trial. Obstet Gynecol 2005; 105:991.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Handmaker NS, Miller WR, Manicke M. Findings of a pilot study of motivational interviewing with pregnant drinkers. J Stud Alcohol 1999; 60:285.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 4798 Version 51.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15703775" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The 4P's Plus screen for substance use in pregnancy: clinical application and outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24150521" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Determinants of alcohol cessation, reduction and no reduction during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34990444" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Alcohol Consumption and Binge Drinking During Pregnancy Among Adults Aged 18-49 Years - United States, 2018-2020.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26401713" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Alcohol use and binge drinking among women of childbearing age - United States, 2011-2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22810267" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Alcohol use and binge drinking among women of childbearing age--United States, 2006-2010.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31022164" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Consumption of Alcohol Beverages and Binge Drinking Among Pregnant Women Aged 18-44 Years - United States, 2015-2017.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18317893" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Alcohol consumption by women before and during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18075488" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Preconception and interconception health status of women who recently gave birth to a live-born infant--Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21775870" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Committee opinion no. 496: At-risk drinking and alcohol dependence: obstetric and gynecologic implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30422199" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36656783" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Alcohol Use, Screening, and Brief Intervention Among Pregnant Persons - 24 U.S. Jurisdictions, 2017 and 2019.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36656783" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Alcohol Use, Screening, and Brief Intervention Among Pregnant Persons - 24 U.S. Jurisdictions, 2017 and 2019.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36656783" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Alcohol Use, Screening, and Brief Intervention Among Pregnant Persons - 24 U.S. Jurisdictions, 2017 and 2019.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36656783" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Alcohol Use, Screening, and Brief Intervention Among Pregnant Persons - 24 U.S. Jurisdictions, 2017 and 2019.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26482673" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Fetal Alcohol Spectrum Disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21172102" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Alcohol use and pregnancy consensus clinical guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21172102" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Alcohol use and pregnancy consensus clinical guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21172102" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Alcohol use and pregnancy consensus clinical guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21172102" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Alcohol use and pregnancy consensus clinical guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17233797" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14638655" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Fetal alcohol spectrum disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29411031" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Prevalence of Fetal Alcohol Spectrum Disorders in 4 US Communities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28586842" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Association Between Prenatal Alcohol Exposure and Craniofacial Shape of Children at 12 Months of Age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25187010" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Study protocol: Asking QUestions about Alcohol in pregnancy (AQUA): a longitudinal cohort study of fetal effects of low to moderate alcohol exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21729235" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Dose-response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)-a systematic review and meta-analyses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22712749" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The effects of low to moderate prenatal alcohol exposure in early pregnancy on IQ in 5-year-old children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22712829" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on selective and sustained attention in 5-year-old children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22712874" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on executive function in 5-year-old children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22712700" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The effect of different alcohol drinking patterns in early to mid pregnancy on the child's intelligence, attention, and executive function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21995343" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Low to moderate alcohol intake during pregnancy and risk of psychomotor deficits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23837773" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on behaviour in 5-year-old children: a prospective cohort study on 1628 children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23837773" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on behaviour in 5-year-old children: a prospective cohort study on 1628 children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23837773" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on behaviour in 5-year-old children: a prospective cohort study on 1628 children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11810954" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Drinking patterns and alcohol-related birth defects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15467586" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Prenatal exposure to binge drinking and cognitive and behavioral outcomes at age 7 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18000129" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Systematic review of the fetal effects of prenatal binge-drinking.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23837772" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Low-to-moderate alcohol consumption during pregnancy and child development--moving beyond observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16260526" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Recognition and prevention of fetal alcohol syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16260526" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Recognition and prevention of fetal alcohol syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22595965" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Prenatal alcohol exposure, blood alcohol concentrations and alcohol elimination rates for the mother, fetus and newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15786496" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Genetic polymorphisms: impact on the risk of fetal alcohol spectrum disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16423594" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Protective effects of the alcohol dehydrogenase-ADH1B allele in children exposed to alcohol during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12461493" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Alcohol dehydrogenase 2 genotypes, maternal alcohol use, and infant outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17618743" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Alcohol dehydrogenase 1B genotype and fetal alcohol syndrome: a HuGE minireview.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11836194" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Moderate alcohol intake during pregnancy and the risk of stillbirth and death in the first year of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34424306" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21306306" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Prenatal alcohol exposure - a systematic review of the effects on child motor function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19187371" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The effect of maternal alcohol consumption on fetal growth and preterm birth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18974425" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Light drinking in pregnancy, a risk for behavioural problems and cognitive deficits at 3 years of age?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20962358" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Investigating the effects of low to moderate levels of prenatal alcohol exposure on child behaviour: a critical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32673615" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Week-by-week alcohol consumption in early pregnancy and spontaneous abortion risk: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32972200" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Association of Prenatal Alcohol Exposure With Psychological, Behavioral, and Neurodevelopmental Outcomes in Children From the Adolescent Brain Cognitive Development Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32972200" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Association of Prenatal Alcohol Exposure With Psychological, Behavioral, and Neurodevelopmental Outcomes in Children From the Adolescent Brain Cognitive Development Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2728952" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self-report screening procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20403013" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2712118" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : The T-ACE questions: practical prenatal detection of risk-drinking.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9610992" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Alcohol use and pregnancy: improving identification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8116829" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Use of the TWEAK test in screening for alcoholism/heavy drinking in three populations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14743939" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Alcohol use in pregnant low-income women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9669791" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Alcohol screening questionnaires in women: a critical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28098942" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Biomarkers for the Detection of Prenatal Alcohol Exposure: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24400931" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Characterization of phosphatidylethanol blood concentrations for screening alcohol consumption in early pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22300909" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Determination of maternal-fetal biomarkers of prenatal exposure to ethanol: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18221928" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Measurement of direct ethanol metabolites suggests higher rate of alcohol use among pregnant women than found with the AUDIT--a pilot study in a population-based sample of Swedish women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18221928" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Measurement of direct ethanol metabolites suggests higher rate of alcohol use among pregnant women than found with the AUDIT--a pilot study in a population-based sample of Swedish women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19037056" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : ACOG Committee Opinion No. 422: at-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23550996" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Comments and reflections on ethics in screening for biomarkers of prenatal alcohol exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23550996" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Comments and reflections on ethics in screening for biomarkers of prenatal alcohol exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15592269" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Pharmacotherapy for pregnant women with addictions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18580882" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Persistence over the first month of neurobehavioral alterations in infants exposed to alcohol prenatally
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10790902" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Brief intervention for alcohol use in pregnancy: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37535355" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Association of Pregnancy-Specific Alcohol Policies With Infant Morbidities and Maltreatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17218187" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Preventing alcohol-exposed pregnancies: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17194863" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Brief intervention for alcohol use by pregnant women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17084796" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Brief intervention for prenatal alcohol use: the role of drinking goal selection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16183466" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Reducing alcohol-exposed pregnancy risk in college women: initial outcomes of a clinical trial of a motivational intervention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15863535" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Brief intervention for prenatal alcohol use: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10091968" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Findings of a pilot study of motivational interviewing with pregnant drinkers.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
